Search research articles
Contact Us
Filters
Showing results (91-100 of 208) with videos related to
Page
of 21
Sort By:
Plos One
|
October 25, 2023
Do deepfake videos undermine our epistemic trust? A thematic analysis of tweets that discuss deepfakes in the Russian invasion of Ukraine
John Twomey, Didier Ching, Matthew Peter Aylett, et al.
Thrombosis and Haemostasis
|
August 28, 2002
Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor
Annapaola Andolfo, William R English, Massimo Resnati, et al.
The Journal of Biological Chemistry
|
February 6, 2002
Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway
Mark Bond, Gillian Murphy, Martin R Bennett, et al.
The Biochemical Journal
|
March 21, 2002
Investigation of the role of Endo180/urokinase-type plasminogen activator receptor-associated protein as a collagenase 3 (matrix metalloproteinase 13) receptor
Louise Bailey, Dirk Wienke, Matthew Howard, et al.
Memory (Hove, England)
|
August 9, 2020
Fool me twice: how effective is debriefing in false memory studies?
Gillian Murphy, Elizabeth Loftus, Rebecca Hofstein Grady, et al.
The Biochemical Journal
|
February 4, 2012
Pentosan polysulfate increases affinity between ADAMTS-5 and TIMP-3 through formation of an electrostatically driven trimolecular complex
Linda Troeberg, Barbara Mulloy, Peter Ghosh, et al.
Plos One
|
May 2, 2025
Can deepfakes manipulate us? Assessing the evidence via a critical scoping review
Didier Ching, John Twomey, Matthew P Aylett, et al.
Journal of Cell Science
|
August 3, 2002
Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs)
Marc A Lafleur, Madeleine M Handsley, Vera Knäuper, et al.
The Biochemical Journal
|
January 31, 2003
Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme
Meng-Huee Lee, Philippa Dodds, Vandana Verma, et al.
The Biochemical Journal
|
June 11, 2010
Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2)
Marie Kveiborg, Jonas Jacobsen, Meng-Huee Lee, et al.
Page
of 21
Search research articles
Search
Showing results (91-100 of 208) with videos related to
Sort By:
Page
of 21
Plos One
|
October 25, 2023
Do deepfake videos undermine our epistemic trust? A thematic analysis of tweets that discuss deepfakes in the Russian invasion of Ukraine
John Twomey, Didier Ching, Matthew Peter Aylett, et al.
Thrombosis and Haemostasis
|
August 28, 2002
Metalloproteases cleave the urokinase-type plasminogen activator receptor in the D1-D2 linker region and expose epitopes not present in the intact soluble receptor
Annapaola Andolfo, William R English, Massimo Resnati, et al.
The Journal of Biological Chemistry
|
February 6, 2002
Tissue inhibitor of metalloproteinase-3 induces a Fas-associated death domain-dependent type II apoptotic pathway
Mark Bond, Gillian Murphy, Martin R Bennett, et al.
The Biochemical Journal
|
March 21, 2002
Investigation of the role of Endo180/urokinase-type plasminogen activator receptor-associated protein as a collagenase 3 (matrix metalloproteinase 13) receptor
Louise Bailey, Dirk Wienke, Matthew Howard, et al.
Memory (Hove, England)
|
August 9, 2020
Fool me twice: how effective is debriefing in false memory studies?
Gillian Murphy, Elizabeth Loftus, Rebecca Hofstein Grady, et al.
The Biochemical Journal
|
February 4, 2012
Pentosan polysulfate increases affinity between ADAMTS-5 and TIMP-3 through formation of an electrostatically driven trimolecular complex
Linda Troeberg, Barbara Mulloy, Peter Ghosh, et al.
Plos One
|
May 2, 2025
Can deepfakes manipulate us? Assessing the evidence via a critical scoping review
Didier Ching, John Twomey, Matthew P Aylett, et al.
Journal of Cell Science
|
August 3, 2002
Endothelial tubulogenesis within fibrin gels specifically requires the activity of membrane-type-matrix metalloproteinases (MT-MMPs)
Marc A Lafleur, Madeleine M Handsley, Vera Knäuper, et al.
The Biochemical Journal
|
January 31, 2003
Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme
Meng-Huee Lee, Philippa Dodds, Vandana Verma, et al.
The Biochemical Journal
|
June 11, 2010
Selective inhibition of ADAM12 catalytic activity through engineering of tissue inhibitor of metalloproteinase 2 (TIMP-2)
Marie Kveiborg, Jonas Jacobsen, Meng-Huee Lee, et al.
Page
of 21